文献速递临床试验与 GCP

简单口服营养补充剂与常规护理对胃癌术后患者疗效比较:多中心、开放标签、平行、随机对照试验的研究方案

The efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial.
PubMed 文献 · Trials · 2024-07-03

本研究为多中心、开放标签、平行、随机对照试验,计划纳入120例将接受胃切除术的胃癌患者,按1:1随机分为口服营养补充剂(ONS)组或常规护理(对照)组。ONS组术后第5至7天起每日接受400 kcal(400 ml)ONS,干预持续术后8周;主要结局为从基线至术后8周体重丢失百分比(%BWL)。

要点

  • 胃切除术后体重丢失影响短期和长期结局,但ONS对体重丢失、肌力和健康相关生活质量的益处尚无一致证据。
  • 本研究旨在评估以碳水化合物和蛋白质为主要成分的ONS对体重丢失、肌力和健康相关生活质量的影响。
  • 若研究结果支持,将向胃癌胃切除术后患者推荐简单营养成分的营养支持。

核心结论

  • 本研究将提供证据说明以简单营养成分组成的ONS能否通过减少胃切除术后体重丢失来改善患者依从性和健康相关生活质量。
  • 若研究结果支持,将向胃癌胃切除术后患者推荐简单营养成分的营养支持。

研究设计与样本

  • 多中心、开放标签、平行、随机对照试验,计划纳入120例将接受胃切除术的胃癌患者,按1:1随机分为ONS组或常规护理(对照)组。
  • 分层因素为临床分期(I期或≥II期)和手术方式(全胃切除术或其他术式)。
  • ONS组术后第5至7天起每日接受400 kcal(400 ml)ONS,干预持续术后8周;对照组给予常规饮食。
  • 主要结局为从基线至术后8周体重丢失百分比(%BWL),所有分析按意向性治疗进行。

关键数值与推荐

  • 主要结局为从基线至术后8周体重丢失百分比(%BWL)。
  • 次要结局包括肌力(握力)、健康相关生活质量(EORTC QLQ-C30、QLQ-OG25、EQ-5D-5L)、营养状态(血红蛋白、淋巴细胞计数、白蛋白)和膳食摄入。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Body weight loss (BWL) after gastrectomy impact on the short- and long-term outcomes. Oral nutritional supplement (ONS) has potential to prevent BWL in patients after gastrectomy. However, there is no consistent evidence supporting the beneficial effects of ONS on BWL, muscle strength and health-related quality of life (HRQoL). This study aimed to evaluate the effects of ONS formulated primarily with carbohydrate and protein on BWL, muscle strength, and HRQoL. METHODS: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥ II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. DISCUSSION: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. TRIAL REGISTRATION: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ueno K, Nishigori T, Tokoro Y, et al. The efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial. Trials. 2024. PMID: 38961505. doi:10.1186/s13063-024-08169-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。